CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,916,619
- in 9 filings, $5.9M under 10b5-1 plans
Net −$5,916,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | Smith Mary L. Director | Grant or award | +4,000 | 9,813 | ||
| 2023-01-05 | Smith Mary L. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-01-05 | Okey Stephanie Director | Grant or award | +4,000 | 5,867 | ||
| 2023-01-05 | Okey Stephanie Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-10-18 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion | +10 | $30.86 | $309 | 61,120 |
| 2022-10-18 | Boulding Mark Elliott EXEC. VP AND CLO | Sale | −10 | $55.45 | $555 | 61,110 |
| 2022-10-18 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion | +289 | $30.86 | $9K | 61,399 |
| 2022-10-18 | Boulding Mark Elliott EXEC. VP AND CLO | Sale | −289 | $55.04 | $16K | 61,110 |
| 2022-10-18 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion · Stock Option (Right to Buy) | −10 | $30.86 | $309 | 62,212 |
| 2022-10-18 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion · Stock Option (Right to Buy) | −289 | $30.86 | $9K | 61,923 |
| 2022-10-17 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion | +200 | $30.86 | $6K | 61,310 |
| 2022-10-17 | Boulding Mark Elliott EXEC. VP AND CLO | Sale | −200 | $55.00 | $11K | 61,110 |
| 2022-10-17 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion | +6,402 | $30.86 | $198K | 67,512 |
| 2022-10-17 | Boulding Mark Elliott EXEC. VP AND CLO | Sale | −6,402 | $55.00 | $352K | 61,110 |
| 2022-10-17 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion · Stock Option (Right to Buy) | −200 | $30.86 | $6K | 68,624 |
| 2022-10-17 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion · Stock Option (Right to Buy) | −6,402 | $30.86 | $198K | 62,222 |
| 2022-09-20 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion | +876 | $30.86 | $27K | 61,986 |
| 2022-09-20 | Boulding Mark Elliott EXEC. VP AND CLO | Sale | −876 | $55.00 | $48K | 61,110 |
| 2022-09-20 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion | +300 | $30.86 | $9K | 61,410 |
| 2022-09-20 | Boulding Mark Elliott EXEC. VP AND CLO | Sale | −300 | $55.00 | $17K | 61,110 |
Page 45 of 53 · 1,049 trades